Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | OTOL1 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
mRNA | SMAD7 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
mRNA | INHBA | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
mRNA | GPSM1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | MICU2 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
mRNA | C5AR1 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
mRNA | PHIP | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
mRNA | PNN | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
mRNA | ETV5 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
mRNA | C3orf20 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |